Cefzil® (cefprozil), Ceftin® (cefuroxime) – Indication removal
November 22, 2016 – The FDA announced the removal of the indication for secondary bacterial infection of acute bronchitis (SBIAB) from the Cefzil (cefprozil) and Ceftin (cefuroxime axetil) drug labels.
Download PDF
